Plasma Expressor Machine Market Trends

Growth Drivers

• An increase in the demand for plasma-derived therapies: These particular therapies are essential for the market since they can aid rare diseases, such as immunodeficiency and hemophilia diseases, by offering crucial antibodies, clotting factors, and proteins. According to an article published by NLM in October 2023, the overall success rate of platelet-rich plasma (PRP) is considered 54.8% and it has been successful for relieving more than 50% of patients globally, thus making it appropriate for the market’s successful growth.
• Surge in blood disorder cases: The aspect of an increase in these diseases that demand plasma-centric therapeutic solutions, including lymphoma, leukemia, hemophilia, and autoimmune disorders, has readily spurred the requirement for the market internationally. As per an article published by the World Health Organization (WHO) in 2025, approximately 40% of children between 6 to 59 months, 37% of pregnant women, and 30% of women between 15 to 49 years are affected with anaemia. Therefore, this has denoted a huge growth opportunity and increased demand for the overall market globally.
• Government strategies for plasma self-sufficiency: This driver is essential for the market to effectively guarantee national health security solutions by offering continuous and timely accessibility to crucial plasma-based medical products. These are suitable for patients, depending on them for successfully aiding illnesses, such as bleeding disorders and immune-based deficiencies. As stated in the 2024 Directorate General of Health Services data report, Blood Transfusion Services effectively supports 1,131 blood banks in India, and based on this, currently there are 4,263 licensed blood facilities, which are positively impacting the market.

Tool Plates 2023 Export and Import Data Uplifting the Plasma Expressor Machine Market

Source: OEC

Challenges

• Absence of regional plasma supply: The market is experiencing minimal hindrance, since a few countries are successfully processing plasma at home, and the majority of nations are effectively dependent on plasma imports. The lack of a significant regional supply of plasma indicates that there is reduced economic, strategic, and operational pressure to retain or procure plasma expressor machines. This has readily resulted in poorly utilized equipment, thereby creating a shrink regarding incentive for investing and developing infrastructure, which are essential for building capacity.
• Capital investment constraints and public payer coverage gaps: The market demands extended infrastructure, which includes educated staff members, safety monitoring, and refrigerators. The government has stated that across low- and middle-income countries, budget constraints have massively diminished the capability of health centers to purchase capital equipment. Besides, purchasing plasma expressor machines has been limited due to a lack of direct funding initiatives through the presence of the public system for either the machinery or the equipment consulting devices.